Menu

Filtros : "FÁRMACOS" "2022" "Financiamento FONDECyT" Removidos: "TEIXEIRA, MANOEL JACOBSEN" "HU-SCIMEND-62" "LOPES, RUBERVAL ARMANDO" "Usp" Limpar

Filtros

Limitar por data

  • 1

1 - 2 (2 registros)

  • Artigo de periodico

    Development and validation of ultraviolet spectrophotometric methods for lamivudine and zidovudine quantification in dissolution test (2022)

    Chauca, Enma Perez ; Plasencia, Pedro M. Alva ; Ferraz, Humberto Gomes

    Fonte: Journal of Pharmacy and Pharmacognosy Research. Unidade: FCF

    Assuntos: ESPECTROFOTOMETRIA, FÁRMACOS

    Acesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      CHAUCA, Enma Perez e PLASENCIA, Pedro M. Alva e FERRAZ, Humberto Gomes. Development and validation of ultraviolet spectrophotometric methods for lamivudine and zidovudine quantification in dissolution test. Journal of Pharmacy and Pharmacognosy Research, v. 10, n. 5, p. 847-856, 2022Tradução . . Disponível em: https://doi.org/10.56499/jppres22.1433_10.5.847. Acesso em: 21 jul. 2024.

    • APA

      Chauca, E. P., Plasencia, P. M. A., & Ferraz, H. G. (2022). Development and validation of ultraviolet spectrophotometric methods for lamivudine and zidovudine quantification in dissolution test. Journal of Pharmacy and Pharmacognosy Research, 10( 5), 847-856. doi:10.56499/jppres22.1433_10.5.847

    • NLM

      Chauca EP, Plasencia PMA, Ferraz HG. Development and validation of ultraviolet spectrophotometric methods for lamivudine and zidovudine quantification in dissolution test [Internet]. Journal of Pharmacy and Pharmacognosy Research. 2022 ; 10( 5): 847-856.[citado 2024 jul. 21 ] Available from: https://doi.org/10.56499/jppres22.1433_10.5.847

    • Vancouver

      Chauca EP, Plasencia PMA, Ferraz HG. Development and validation of ultraviolet spectrophotometric methods for lamivudine and zidovudine quantification in dissolution test [Internet]. Journal of Pharmacy and Pharmacognosy Research. 2022 ; 10( 5): 847-856.[citado 2024 jul. 21 ] Available from: https://doi.org/10.56499/jppres22.1433_10.5.847

  • Artigo de periodico

    Contribution of microRNAs in chemoresistance to cisplatin in the top five deadliest cancer: an updated review (2022)

    Reyes, Pia Loren ; Saavedra, Nicolás ; Torso, Nadine de Godoy ; Visacri, Marilia Berlofa ; Moriel, Patricia ; Salazar, Luis Antônio

    Fonte: Frontiers in Pharmacology. Unidade: FCF

    Assuntos: FÁRMACOS, MICRORNAS

    Versão PublicadaAcesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      REYES, Pia Loren et al. Contribution of microRNAs in chemoresistance to cisplatin in the top five deadliest cancer: an updated review. Frontiers in Pharmacology, v. 13, p. 1-19, 2022Tradução . . Disponível em: https://doi.org/10.3389/fphar.2022.831099. Acesso em: 21 jul. 2024.

    • APA

      Reyes, P. L., Saavedra, N., Torso, N. de G., Visacri, M. B., Moriel, P., & Salazar, L. A. (2022). Contribution of microRNAs in chemoresistance to cisplatin in the top five deadliest cancer: an updated review. Frontiers in Pharmacology, 13, 1-19. doi:10.3389/fphar.2022.831099

    • NLM

      Reyes PL, Saavedra N, Torso N de G, Visacri MB, Moriel P, Salazar LA. Contribution of microRNAs in chemoresistance to cisplatin in the top five deadliest cancer: an updated review [Internet]. Frontiers in Pharmacology. 2022 ; 13 1-19.[citado 2024 jul. 21 ] Available from: https://doi.org/10.3389/fphar.2022.831099

    • Vancouver

      Reyes PL, Saavedra N, Torso N de G, Visacri MB, Moriel P, Salazar LA. Contribution of microRNAs in chemoresistance to cisplatin in the top five deadliest cancer: an updated review [Internet]. Frontiers in Pharmacology. 2022 ; 13 1-19.[citado 2024 jul. 21 ] Available from: https://doi.org/10.3389/fphar.2022.831099
  • 1

1 - 2 (2 registros)

Biblioteca Digital de Produção Intelectual da Universidade de São Paulo     2012 - 2024